Viewing Study NCT00883051


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-01-03 @ 4:37 AM
Study NCT ID: NCT00883051
Status: COMPLETED
Last Update Posted: 2019-12-23
First Post: 2009-04-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COL-144 View
None acute treatment View
None migraine View